Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02420509 · ClinicalTrials.gov registry record
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
A clinical trial, sponsored by University of California, San Diego.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02420509: Clinical Trial study, sponsored by University of California, San Diego.
NCT02420509 is a clinical trial that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02420509 was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if postoperative chemotherapy in patients with high-grade appendix cancer after surgery improves outcomes. The postoperative chemotherapy will consist of 5-FU (with leucovorin) or capecitabine with bevacizumab. These drugs are approved for use in people with colon cancer, and they are used at UCSD for some patients with appendix cancer. The purpose of this study is to explore the safety and efficacy of the postoperative chemotherapy treatment on cancer.
Primary Outcome
PFS will be measured from the time of the start of postoperative chemotherapy until disease progression or death during the total study period (four years)
Interventions
- DRUG systemic chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-08-27 |
| Est. Completion | 2019-04-02 |
Why NCT02420509 stopped before completion
NCT02420509 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which systemic chemotherapy is the first listed.
NCT02420509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02420509 about?
NCT02420509 is a clinical study titled "Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis". The purpose of this study is to find out if postoperative chemotherapy in patients with high-grade appendix cancer after surgery improves outcomes. The postoperative chemotherapy will consist of 5-FU (with leucovorin) or capecitabine with bevacizumab. These drugs are approved for use in people with...
What is the current status of trial NCT02420509?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2015-08-27. Estimated completion is 2019-04-02.
What interventions are being tested in trial NCT02420509?
The interventions under investigation include: systemic chemotherapy (DRUG).
Who is sponsoring clinical trial NCT02420509?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI